XNAS · Healthcare · Health Information Services
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | Q1 2026 | -1.55 | -1.34 | +13.55% | $21,140 | ✅ Beat | +1.52% | -2.74% | — |
| 2026-03-18 | Q4 2025 | -3.28 | -2.01 | +38.72% | $18,479 | ✅ Beat | -0.60% | -2.71% | +2.11% |
| 2025-11-12 |
| Q3 2025 |
| -2.64 |
| -2.93 |
| -10.98% |
| $18,942 |
| ❌ Miss |
| — |
| — |
| — |
| 2025-08-14 | Q2 2025 | -2.26 | -2.75 | -21.68% | $19,319 | ❌ Miss | +2.16% | +1.50% | +7.78% |
| 2025-04-09 | Q4 2024 | -1356.74 | -986.50 | +27.29% | $10,232 | ✅ Beat | -2.61% | +3.29% | -19.41% |
| 2024-11-14 | Q3 2024 | -1698.30 | -1498.50 | +11.76% | $14,407 | ✅ Beat | -3.88% | +5.30% | -39.08% |
| 2024-08-14 | Q2 2024 | -1898.10 | -1498.50 | +21.05% | $10,971 | ✅ Beat | +10.48% | +10.96% | -8.65% |
| 2024-05-15 | Q1 2024 | — | -4395.60 | — | $10,114 | — | +17.99% | +20.14% | +7.88% |
Showing last 8 quarters.